Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma

por Brady, Samuel L., Shulkin, Barry L.
Publicado 2019

Efficacy of radioactive iodine treatment of graves’ hyperthyroidism using a single calculated (131)I dose

por Wong, Ka Kit, Shulkin, Barry L., Gross, Milton D., Avram, Anca M.
Publicado 2018

CD19 CAR T-cell therapy demonstrates activity against extramedullary disease in pediatric patients with B-ALL

por Epperly, Rebecca, Shulkin, Barry L., Bag, Asim K., Cheng, Cheng, Inaba, Hiroto, Lucas, John T., Naik, Swati, Triplett, Brandon M., Gottschalk, Stephen, Talleur, Aimee C.
Publicado 2023

Radiomics Features Differentiate Between Normal and Tumoral High-Fdg Uptake

por Hsu, Chih-Yang, Doubrovin, Mike, Hua, Chia-Ho, Mohammed, Omar, Shulkin, Barry L., Kaste, Sue, Federico, Sara, Metzger, Monica, Krasin, Matthew, Tinkle, Christopher, Merchant, Thomas E., Lucas, John T.
Publicado 2018

SNMMI Procedure Standard/EANM Practice Guideline on Pediatric (18)F-FDG PET/CT for Oncology 1.0

por Vali, Reza, Alessio, Adam, Balza, Rene, Borgwardt, Lise, Bar-Sever, Zvi, Czachowski, Michael, Jehanno, Nina, Kurch, Lars, Pandit-Taskar, Neeta, Parisi, Marguerite, Piccardo, Arnoldo, Seghers, Victor, Shulkin, Barry L., Zucchetta, Pietro, Lim, Ruth
Publicado 2021

Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma

por Lucas, John Thomas, Wakefield, Daniel Victor, Doubrovin, Michael, Li, Yimei, Santiago, Teresa, Federico, Sara Michele, Merchant, Thomas E., Davidoff, Andrew M., Krasin, Matthew J., Shulkin, Barry L., Santana, Victor M., Lee Furman, Wayne
Publicado 2022

(11)C-Methionine PET for Identification of Pediatric High-Grade Glioma Recurrence

por Bag, Asim K., Wing, Melissa N., Sabin, Noah D., Hwang, Scott N., Armstrong, Gregory T., Han, Yuanyuan, Li, Yimei, Snyder, Scott E., Robinson, Giles W., Qaddoumi, Ibrahim, Broniscer, Alberto, Lucas, John T., Shulkin, Barry L.
Publicado 2022

Value of the Sentinel Node Procedure in Pediatric Extremity Rhabdomyosarcoma: A Systematic Review and Retrospective Cohort Study

por Jeremiasse, Bernadette, van der Steeg, Alida F. W., Fiocco, Marta, Hobbelink, Monique G. G., Merks, Johannes H. M., Godzinski, Jan, Shulkin, Barry L., Wijnen, Marc H. W. A., Terwisscha van Scheltinga, Cecilia E. J.
Publicado 2021

Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [(18)F]FDG: version 1.0

por Piccardo, Arnoldo, Albert, Nathalie L., Borgwardt, Lise, Fahey, Frederic H., Hargrave, Darren, Galldiks, Norbert, Jehanno, Nina, Kurch, Lars, Law, Ian, Lim, Ruth, Lopci, Egesta, Marner, Lisbeth, Morana, Giovanni, Young Poussaint, Tina, Seghers, Victor J., Shulkin, Barry L., Warren, Katherine E., Traub-Weidinger, Tatjana, Zucchetta, Pietro
Publicado 2022

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology...

por Ozkaynak, M. Fevzi, Gilman, Andrew L., London, Wendy B., Naranjo, Arlene, Diccianni, Mitchell B., Tenney, Sheena C., Smith, Malcolm, Messer, Karen S., Seeger, Robert, Reynolds, C. Patrick, Smith, L. Mary, Shulkin, Barry L., Parisi, Marguerite, Maris, John M., Park, Julie R., Sondel, Paul M., Yu, Alice L.
Publicado 2018

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Childr...

por Ozkaynak, M. Fevzi, Gilman, Andrew L., London, Wendy B., Naranjo, Arlene, Diccianni, Mitchell B., Tenney, Sheena C., Smith, Malcolm, Messer, Karen S., Seeger, Robert, Reynolds, C. Patrick, Smith, L. Mary, Shulkin, Barry L., Parisi, Marguerite, Maris, John M., Park, Julie R., Sondel, Paul M., Yu, Alice L.
Publicado 2018

Metabolic response as assessed by (18)F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rha...

por Harrison, Douglas J., Chi, Yueh‐Yun, Tian, Jing, Hingorani, Pooja, Mascarenhas, Leo, McCowage, Geoffrey B., Weigel, Brenda J., Venkatramani, Rajkumar, Wolden, Suzanne L., Yock, Torunn I., Rodeberg, David A., Hayes‐Jordan, Andrea A., Teot, Lisa A., Spunt, Sheri L., Meyer, William H., Hawkins, Douglas S., Shulkin, Barry L., Parisi, Marguerite T.
Publicado 2020

KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: a report from the Children’s Oncology Group

por Erbe, Amy K, Diccianni, Mitch B, Mody, Rajen, Naranjo, Arlene, Zhang, Fan F, Birstler, Jen, Kim, KyungMann, Feils, Arika S, Hung, Jung-Tung, London, Wendy B, Shulkin, Barry L, Mathew, Varsha, Parisi, Marguerite T, Servaes, Sabah, Asgharzadeh, Shahab, Maris, John M, Park, Julie, Yu, Alice L, Sondel, Paul M, Bagatell, Rochelle
Publicado 2023